Emerging therapeutic targets and agents for glioblastoma migrating cells

Anti-Cancer Agents in Medicinal Chemistry

Volumn 10, Issue 7, 2010, Pages 543-555

  Di, Chunhui ^a   Mattox, Austin K ^a   Harward, Stephen ^a   Adamson, Cory ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

AJAP; Chemotherapy; Glioblastoma; Tumor cell migration

Indexed keywords

1 (1 CYANO 1 METHYLETHYL) 3 METHYL 8 (3 QUINOLINYL)IMIDAZO[4,5 C]QUINOLIN 2(1H,3H) ONE; 4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 6 [4 (4 ETHYL 1 PIPERAZINYLMETHYL)PHENYL] 4 (ALPHA METHYLBENZYLAMINO) 7H PYRROLO[2,3 D]PYRIMIDINE; AP 12009; AZD 4547; CYTOKINE; DASATINIB; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; FIBROBLAST GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; GEFITINIB; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GROWTH FACTOR; IMATINIB; IMMUNOGLOBULIN; INTEGRIN; LAPATINIB; LLL 12; N [4 (3 CHLORO 4 FLUOROANILINO) 7 (TETRAHYDRO 3 FURYLOXY) 6 QUINAZOLINYL] 4 DIMETHYLAMINO 2 BUTENAMIDE; PAZOPANIB; PERIFOSINE; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; SORAFENIB; TANDUTINIB; TLN 4601; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; UROKINASE; VATALANIB; WP 1034; WX 671; XL 184; XL 765;

ARTICLE; CANCER CONTROL; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL SURFACE; DRUG TARGETING; EXTRACELLULAR MATRIX; GLIOBLASTOMA; GLIOMA CELL; HUMAN; NONHUMAN; PHENOTYPE; SIGNAL TRANSDUCTION; TARGET CELL;

EID: 78649882830     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152010793498618     Document Type: Article

References (136)

1. Scherer, H. J. The forms of growth in gliomas and their practicalsignificance. Brain 1940, 63, 1-35.
2. Cavallaro, U.; Christofori, G. Cell adhesion and signalling bycadherins and Ig-CAMs in cancer. Nat. Rev. Cancer, 2004, 4(2), 118-132.
3. Sasaki, H.; Yoshida, K.; Ikeda, E.; Asou, H.; Inaba, M.; Otani, M.; Kawase, T. Expression of the neural cell adhesionmolecule in astrocytic tumors. Cancer, 1998, 82(10), 1921-1931.
4. Ranuncolo, S. M.; Ladeda, V.; Specterman, S.; Varela, M.; Lastiri, J.; Morandi, A.; Matos, E.; Joffe, E. B. D. K.; Puricelli, L.; Pallotta, M. G. CD44 expression in human gliomas. J. Surg. Oncol., 2002, 79(1), 30-36.
5. Piao, Y.; Lu, L.; de Groot, J. AMPA receptors promoteperivascular glioma invasion via β1 integrin-dependent adhesion tothe extracellular matrix. Neuro-Oncology, 2009, 11(3), 260-273.
6. Van Lint, P.; Libert, C. Chemokine and cytokine processing bymatrix metalloproteinases and its effect on leukocyte migration and inflammation. J. Leukoc. Biol., 2007, 82(6), 1375-1381.
7. Silveira Corrêa, T. C.; Massaro, R. R.; Brohem, C. A.; Taboga, S.R.; Lamers, M. L.; Santos, M. F.; Maria-Engler, S. S. RECKmediatedinhibition of glioma migration and invasion. J. Cell.Biochem., 2010, 110(1), 52-61.
8. Mikheeva, S.; Mikheev, A.; Petit, A.; Beyer, R.; Oxford, R.; Khorasani, L.; Maxwell, J.-P.; Glackin, C.; Wakimoto, H.; Gonzalez-Herrero, I.; Sanchez-Garcia, I.; Silber, J.; Horner, P.; Rostomily, R. TWIST1 promotes invasion through mesenchymalchange in human glioblastoma. Mol. Cancer, 2010, 9(1), 194.
9. Engebraaten, O.; Bjerkvig, R.; Pedersen, P.; Laerum, O. Effectsof EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratoryand invasive capacities of human brain-tumour biopsies in vitro.Int. J. Cancer, 1993, 53(2), 209-214.
10. Pedersen, P.-H.; Ness, G.; Engebraaten, O.; Bjerkvig, R.; Lillehaug, J.; Laerum, O.Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF-a, bFGF, IL-2] on glioma spheriod growth, migration and invasion. Int. J. Cancer, 1994, 56(2), 255-261.
11. Koochekpour, S.; Merzak, A.; Pilkington, G. J. Growth factors and gangliosidesstimulate laminin production by human glioma cells in vitro.Neurosci. Lett., 1995, 186(1), 53-56.
12. Zwick, E.; Bange, J.; Ullrich, A. Receptor tyrosine kinasesignalling as a target for cancer intervention strategies. Endocr.Relat. Cancer, 2001, 8(3), 161-173.
13. Robinson, D. R.; Wu, Y.-M.; Lin, S.-F. The protein tyrosine kinasefamily of the human genome. Oncogene, 2000, 19(49), 5548-5557.
14. Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell, 2000, 103(2), 211-225.
15. Singer, E.; Landgraf, R.; Horan, T.; Slamon, D.; Eisenberg, D.Identification of a heregulin binding site in HER3 extracellulardomain. J. Biol. Chem., 2001, 276(47), 44266-44274.
16. CarrawayIII, K. L.; Weber, J. L.; Unger, M. J.; Ledesma, J.; Yu, N.; Gassmann, M.; Lai, C. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature, 1997, 387(6632), 512-516.
17. Yoo, J.-Y.; Wang, X.W.; Rishi, A. K.; Lessor, T.; Xia, X.-M.; Gustafson, T. A.; Hamburger, A. W. Interaction of the PA2G4(EBP1) protein with ErbB-3 and regulation of this binding byheregulin. Br. J. Cancer, 2000, 82(3), 683-690.
18. Thaminy, S.; Auerbach, D.; Arnoldo, A.; Stagljar, I. Identificationof novel ErbB3-interacting factors using the split-ubiquitinmembrane yeast two-hybrid system. Genome Res., 2003, 13(7), 1744-1753.
19. Williams, C. C.; Allison, J. G.; Vidal, G. A.; Burow, M. E.; Beckman, B. S.; Marrero, L.; Jones, F. E. The ERBB4/HER4receptor tyrosine kinase regulates gene expression by functioningas a STAT5A nuclear chaperone. J. Cell Biol., 2004, 167(3), 469-478.
20. Schulze, W. X.; Deng, L.; Mann, M. Phosphotyrosineinteractome of the ErbB-receptor kinase family. Mol. Syst. Biol., 2005, 1, 2005.0008.
21. Garcia, R. A. G.; Vasudevan, K.; Buonanno, A. The neuregulinreceptor ErbB-4 interacts with PDZ-containing proteins at neuronalsynapses. Proc.Natl. Acad. Sci. USA, 2000, 97(7), 3596-3601.
22. Huang, Y. Z.; Won, S.; Ali, D. W.; Wang, Q.; Tanowitz, M.; Du, Q. S.; Pelkey, K. A.; Yang, D. J.; Xiong, W. C.; Salter, M. W.; Mei, L. Regulation of neuregulin signaling by PSD-95 interactingwith ErbB4 at CNS synapses. Neuron, 2000, 26(2), 443-455.
23. Gambarotta, G.; Garzotto, D.; Destro, E.; Mautino, B.; Giampietro, C.; Cutrupi, S.; Dati, C.; Cattaneo, E.; Fasolo, A.; Perroteau, I.ErbB4 Expression in neural progenitor cells (ST14A) is necessaryto mediate neuregulin-1β1-induced migration. J. Biol. Chem., 2004, 279(47), 48808-48816.
24. Davies, G. C.; Ryan, P. E.; Rahman, L.; Zajac-Kaye, M.; Lipkowitz, S. EGFRvIII undergoes activation-dependentdownregulation mediated by the Cbl proteins. Oncogene, 2006, 25(49), 6497-6509.
25. Micallef, J.; Taccone, M.; Mukherjee, J.; Croul, S.; Busby, J.; Moran, M. F.; Guha, A. Epidermal growth factor receptor variantIII-induced glioma invasion is mediated through myristoylatedalanine-rich protein kinase C substrate overexpression. CancerRes., 2009, 69(19), 7548-7556.
26. Huang, P. H.; Xu, A. M.; White, F. M. Oncogenic EGFR signalingnetworks in glioma. Sci. Signal., 2009, 2(87), re6.
27. Cancer Genome Atlas Research Network. Comprehensive genomiccharacterization defines human glioblastoma genes and corepathways. Nature, 2008, 455(7216), 1061-8.
28. Gough, N. R. From Ras to PI3K. Sci. Signal., 2006, 2006(362), tw397.
29. Abounader, R. Interactions between PTEN and receptor tyrosinekinase pathways and their implications for glioma therapy. ExpertRev. Anticancer Ther., 2009, 9(2), 235-245.
30. Kleber, S.; Sancho-Martinez, I.; Wiestler, B.; Beisel, A.; Gieffers, C.; Hill, O.; Thiemann, M.; Mueller, W.; Sykora, J.; Kuhn, A.; Schreglmann, N.; Letellier, E.; Zuliani, C.; Klussmann, S.; Teodorczyk, M.; Gröne, H.-J.; Ganten, T. M.; Sültmann, H.; Tüttenberg, J.; von Deimling, A.; Regnier-Vigouroux, A.; Herold-Mende, C.; Martin-Villalba, A. Yes and PI3K bind CD95 to signalinvasion of glioblastoma. Cancer Cell, 2008, 13(3), 235-248.
31. Sansal, I.; Sellers, W. R. The biology and clinical relevance of thePTEN tumor suppressor pathway. J. Clin. Oncol., 2004, 22(14), 2954-2963.
32. Sonoda, Y.; Ozawa, T.; Aldape, K. D.; Deen, D. F.; Berger, M. S.; Pieper, R. O. Akt pathway activation converts anaplasticastrocytoma to glioblastoma multiforme in a human astrocytemodel of glioma. Cancer Res., 2001, 61(18), 6674-6678.
33. Van Brocklyn, J. R.; Young, N.; Roof, R. Sphingosine-1-phosphate stimulates motility and invasiveness of humanglioblastoma multiforme cells. Cancer Lett., 2003, 199(1), 53-60.
34. Malchinkhuu, E.; Sato, K.; Maehama, T.; Mogi, C.; Tomura, H.; Ishiuchi, S.; Yoshimoto, Y.; Kurose, H.; Okajima, F. S1P2receptors mediate inhibition of glioma cell migration through Rhosignaling pathways independent of PTEN. Biochem. Biophys. Res.Commun., 2008, 366(4), 963-968.
35. Young, N.; Pearl, D. K.; Van Brocklyn, J. R. Sphingosine-1-phosphate regulates glioblastomacell invasiveness through the urokinase plasminogen activatorsystem and CCN1/Cyr61. Mol. Cancer Res., 2009, 7(1), 23-32.
36. Young, N.; Van Brocklyn, J. R. Roles of sphingosine-1-phosphate(S1P) receptors in malignant behavior of glioma cells. Differentialeffects of S1P2 on cell migration and invasiveness. Expert. CellRes., 2007, 313 (8), 1615-1627.
37. Amos, S.; Redpath, G. T.; diPierro, C. G.; Carpenter, J. E.; Hussaini, I. M. Epidermal growth factor receptor-mediatedregulation of urokinase plasminogen activator expression and glioblastoma invasion via C-SRC/MAPK/AP-1 signaling pathways.J. Neuropathol. Expert Neurol., 2010, 69(6), 582-592.
38. Zhao, Y.; Xiao, A.; diPierro, C. G.; Carpenter, J. E.; Abdel-Fattah, R.; Redpath, G. T.; Lopes, M.-B. S.; Hussaini, I. M. An extensiveinvasive intracranial human glioblastoma xenograft model: role of high level matrix metalloproteinase 9. Am. J. Pathol., 2010, 176(6), 3032-3049.
39. Mukherjee, J.; DeSouza, L. V.; Micallef, J.; Karim, Z.; Croul, S.; Siu, K. W. M.; Guha, A. Loss of collapsin response mediatorprotein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII. Cancer Res., 2009, 69(22), 8545-8554.
40. Gan, H. K.; Kaye, A. H.; Luwor, R. B. The EGFRvIII variant inglioblastoma multiforme. J. Clin. Neurosci., 2009, 16(6), 748-754.
41. Hata, N.; Shinojima, N.; Gumin, J.; Yong, R.; Marini, F.; Andreeff, M.; Lang, F. F. Platelet-derived growth factor BB mediates thetropism of human mesenchymal stem cells for malignant gliomas.Neurosurgery, 2010, 66(1), 144-157.
42. Feldkamp, M. M.; Lau, N.; Guha, A. Signal transduction pathwaysand their relevance in human astrocytomas. J. Neuro-Oncology, 1997, 35(3), 223-248.
43. de Boüard, S.; Herlin, P.; Christensen, J. G.; Lemoisson, E.; Gauduchon, P.; Raymond, E.; Guillamo, J.-S. Antiangiogenic and anti-invasive effects of sunitinib on experimental humanglioblastoma. Neuro-Oncology, 2007, 9(4), 412-423.
44. Hoelzinger, D. B.; Demuth, T.; Berens, M. E. Autocrine factorsthat sustain glioma invasion and paracrine biology in the brainmicroenvironment. J. Nat. Cancer Inst., 2007, 99(21), 1583-1593.
45. Fukai, J.; Yokote, H.; Yamanaka, R.; Arao, T.; Nishio, K.; Itakura, T. EphA4 promotes cell proliferation and migration through anovel EphA4-FGFR1 signaling pathway in the human glioma U251cell line. Mol. Cancer Ther., 2008, 7(9), 2768-2778.
46. Dodelet, V. C.; Pasquale, E. B. Eph receptors and ephrinligands: embryogenesis to tumorigenesis. Oncogene, 2000, 19(49), 5614-5619.
47. Wimmer-Kleikamp, S. H.; Lackmann, M. Ephmodulatedcell morphology, adhesion and motility incarcinogenesis. IUBMB Life, 2005, 57(6), 421-431.
48. Wykosky, J.; Debinski, W. The EphA2 receptor and ephrinA1ligand in solid tumors: function and therapeutic targeting. Mol.Cancer Res., 2008, 6(12), 1795-1806.
49. Nakada, M.; Drake, K. L.; Nakada, S.; Niska, J. A.; Berens, M. E.Ephrin-B3 ligand promotes glioma invasion through activation of Rac1. Cancer Res., 2006, 66(17), 8492-500.
50. Nakada, M.; Niska, J. A.; Miyamori, H.; McDonough, W. S.; Wu, J.; Sato, H.; Berens, M. E. The phosphorylation of EphB2 receptorregulates migration and invasion of human glioma cells. CancerRes., 2004, 64(9), 3179-85.
51. Allerstorfer, S.; Sonvilla, G.; Fischer, H.; Spiegl-Kreinecker, S.; Gauglhofer, C.; Setinek, U.; Czech, T.; Marosi, C.; Buchroithner, J.; Pichler, J.; Silye, R.; Mohr, T.; Holzmann, K.; Grasl-Kraupp, B.; Marian, B.; Grusch, M.; Fischer, J.; Micksche, M.; Berger, W.FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities. Oncogene, 2008, 27(30), 4180-4190.
52. Koochekpour, S.; Jeffers, M.; Rulong, S.; Taylor, G.; Klineberg, E.; Hudson, E. A.; Resau, J. H.; Vande Woude, G. F. Met and hepatocyte growth factor/scatter factor expression in humangliomas. Cancer Res., 1997, 57(23), 5391-8.
53. Xie, Q.; Gao, C.-F.; Shinomiya, N.; Sausville, E.; Hay, R.; Gustafson, M.; Shen, Y.; Wenkert, D.; Woude, G. F. V.Geldanamycins exquisitely inhibit HGF//SF-mediated tumor cellinvasion. Oncogene, 2005, 24(23), 3697-3707.
54. Li, Y.; Guessous, F.; DiPierro, C.; Zhang, Y.; Mudrick, T.; Fuller, L.; Johnson, E.; Marcinkiewicz, L.; Engelhardt, M.; Kefas, B.; Schiff, D.; Kim, J.; Abounader, R. Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy.Mol. Cancer Ther., 2009, 8(2), 376-385.
55. Esencay, M.; Newcomb, E.; Zagzag, D. HGF upregulates CXCR4expression in gliomas via NF-κB: implications for glioma cellmigration. J. Neuro-Oncol., 2010, 99(1), 33-40.
56. Ihle, J. N.; Kerr, I. M. Jaks and Stats in signaling by thecytokine receptor superfamily. Trends Genet., 1995, 11(2), 69-74.
57. Bromberg, J.; Chen, X. STAT proteins: signal tranducers and activators of transcription. Methods Enzymol., 2001, 333, 138-151.
58. de la Iglesia, N.; Konopka, G.; Lim, K.-L.; Nutt, C. L.; Bromberg, J. F.; Frank, D. A.; Mischel, P. S.; Louis, D. N.; Bonni, A.Deregulation of a STAT3-interleukin 8 signaling pathwaypromotes human glioblastoma cell proliferation and invasiveness.J. Neurosci., 2008, 28(23), 5870-5878.
59. Lin, L.; Hutzen, B.; Li, P.-K.; Ball, S.; Zuo, M.; DeAngelis, S.; Foust, E.; Sobo, M.; Friedman, L.; Bhasin, D.; Cen, L.; Li, C.; Lin, J. A novel small molecule, LLL12, inhibits STAT3phosphorylation and activities and exhibits potent growthsuppressiveactivity in human cancer cells. Neoplasia, 2010, 12(1), 39-50.
60. Song, H.; Moon, A. Glial cell-derived neurotrophic factor (GDNF)promotes low-grade Hs683 glioma cell migration through JNK, ERK-1/2 and p38 MAPK signaling pathways. Neurosci. Res., 2006, 56(1), 29-38.
61. Weller, M.; Fontana, A. The failure of current immunotherapy formalignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain. Brain Res. Rev., 1995, 21(2), 128-151.
62. Wrana, J.; Attisano, L.; Wieser, R.; Ventura, F.; Massagué, J.Mechanism of activation of the TGF-beta receptor. Nature, 1994, 370, 341-347.
63. Hjelmeland, M. D.; Hjelmeland, A. B.; Sathornsumetee, S.; Reese, E. D.; Herbstreith, M. H.; Laping, N. J.; Friedman, H. S.; Bigner, D. D.; Wang, X.-F.; Rich, J. N. SB-431542, a small moleculetransforming growth factor-β-receptor antagonist, inhibits humanglioma cell line proliferation and motility. Mol. Cancer Ther., 2004, 3(6), 737-745.
64. Merzak, A.; McCrea, S.; Koocheckpour, S.; Pilkington, G. J.Control of human glioma cell growth, migration and invasion invitro by transforming growth factor beta 1. Br. J. Cancer, 1994, 70(2), 199-203.
65. Nakano, A.; Tani, E.; Miyazaki, K.; Yamamoto, Y.; Furuyama, J.-i. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J.Neurosurg., 2009, 83(2), 298-307.
66. Huijbers, I. J.; Iravani, M.; Popov, S.; Robertson, D.; Al-Sarraj, S.; Jones, C.; Isacke, C. M. A role for fibrillar collagen deposition and the collagen internalization receptor Endo180 in glioma invasion.PLoS ONE, 2010, 5(3), e9808.
67. Sciumè, G.; Soriani, A.; Piccoli, M.; Frati, L.; Santoni, A.; Bernardini, G. CX3CR1/CX3CL1 axis negatively controls gliomacell invasion and is modulated by transforming growth factorbeta1.Neuro-Oncology, 2010, 12(7), 701-710.
68. Hynes, R. O. Integrins: bidirectional, allosteric signaling machines.Cell, 2002, 110(6), 673-687.
69. Gladson, C. L.; Wilcox, J. N.; Sanders, L.; Gillespie, G. Y.; Cheresh, D. A. Cerebral microenvironment influences expressionof the vitronectin gene in astrocytic tumors. J. Cell Sci., 1995, 108(3), 947-956.
70. Friedlander, D. R.; Zagzag, D.; Shiff, B.; Cohen, H.; Allen, J. C.; Kelly, P. J.; Grumet, M. Migration of braintumor cells on extracellular matrix proteins in vitro correlates withtumor type and grade and involves αv and β1 integrins. CancerRes., 1996, 56(8), 1939-1947.
71. Wild-Bode, C.; Weller, M.; Rimner, A.; Dichgans, J.; Wick, W. Sublethal irradiation promotesmigration and invasiveness of glioma cells. Cancer Res., 2001, 61(6), 2744-2750.
72. Chen, H.-C.; Guan, J.-L. Association of focal adhesion kinasewith its potential substrate phosphatidylinositol 3-kinase. Proc.Natl. Acad. Sci. USA, 1994, 91(21), 10148-10152.
73. Cobb, B. S.; Schaller, M. D.; Leu, T. H.; Parsons, J. T. Stable association of pp60src and pp59fyn with the focal adhesion-associated proteintyrosine kinase, pp125FAK. Mol. Cell. Biol., 1994, 14(1), 147-155.
74. Schaller, M. D.; Thomas Parsons, J. Focal adhesion kinase and associated proteins. Curr. Opin. Cell Biol., 1994, 6(5), 705-710.
75. Zhang, X.; Chattopadhyay, A.; Ji, Q.-s.; Owen, J. D.; Ruest, P. J.; Carpenter, G.; Hanks, S. K. Focal adhesion kinase promotesphospholipase C-β1 activity. Proc. Natl. Acad. Sci. USA, 1999, 96(16), 9021-9026.
76. Avraham, H.; Park, S.-Y.; Schinkmann, K.; Avraham, S.RAFTK/Pyk2-mediated cellular signalling. Cell. Signal., 2000, 12(3), 123-133.
77. Obara, S.; Nakata, M.; Takeshima, H.; Kuratsu, J.-i.; Maruyama, I.; Kitajima, I. Inhibition of migration of humanglioblastoma cells by cerivastatin in association with focal adhesionkinase (FAK). Cancer Lett., 2002, 185(2), 153-161.
78. Zagzag, D.; Nomura, M.; David, R. F.; Blanco, C. Y.; Gagner, J.-P.; Nomura, N.; Newcomb, E. W. Geldanamycin inhibits migration of gliomacells in vitro: A potential role for hypoxia-inducible factor (HIF-1alpha) in glioma cell invasion. J. Cell. Physiol., 2003, 196(2), 394-402.
79. Ling, J.; Liu, Z.; Wang, D.; Gladson, C. L. Malignantastrocytoma cell attachment and migration to various matrixproteins is differentially sensitive to phosphoinositide 3-OH kinaseinhibitors. J. Cell Biochem., 1999, 73(4), 533-544.
80. Varga, I.; Hutoczki, G.; Petras, M.; Scholtz, B.; Miko, E.; Kenyeres, A.; Toth, J.; Zahuczky, G.; Bognar, L.; Hanzely, Z.; Klekner, A. Expression of invasion-related extracellular matrixmolecules in human glioblastoma versus intracerebral lungadenocarcinoma metastasis. Cen. Eur. Neurosurg., 2010, [Epubahead of Print].
81. Ulrich, T. A.; de Juan Pardo, E. M.; Kumar, S. The mechanicalrigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells. Cancer Res., 2009, 69(10), 4167-4174.
82. Sarkar, S.; Nuttall, R. K.; Liu, S.; Edwards, D. R.; Yong, V. W.Tenascin-C stimulates glioma cell invasion through matrixmetalloproteinase-12. Cancer Res., 2006, 66(24), 11771-11780.
83. Ziu, M.; Schmidt, N. O.; Cargioli, T. G.; Aboody, K. S.; Black, P.M.; Carroll, R. S. Glioma-produced extracellular matrix influencesbrain tumor tropism of human neural stem cells. J. Neuro-Oncol., 2006, 79(2), 125-133.
84. Hu, B.; Jarzynka, M. J.; Guo, P.; Imanishi, Y.; Schlaepfer, D. D.; Cheng, S. Y. Angiopoietin 2 induces glioma cell invasion bystimulating matrix metalloprotease 2 expression through thealphavbeta1 integrin and focal adhesion kinase signaling pathway.Cancer Res., 2006, 66(2), 775-83.
85. Xie, D.; Yin, D.; Tong, X.; O'Kelly, J.; Mori, A.; Miller, C.; Black, K.; Gui, D.; Said, J. W.; Koeffler, H. P. Cyr61 is overexpressed ingliomas and involved in integrin-linked kinase-mediated Akt and β-catenin-TCF/Lef signaling pathways. Cancer Res., 2004, 64(6), 1987-1996.
86. Fortin, S.; Mercier, M. L.; Camby, I.; Spiegl-Kreinecker, S.; Berger, W.; Lefranc, F.; Kiss, R. Galectin-1 is implicated in theprotein kinase C ε/vimentin-controlled trafficking of integrin-β1 inglioblastoma Cells. Brain Pathol., 2010, 20(1), 39-49.
87. Thomas, S. L.; Alam, R.; Lemke, N.; Schultz, L. R.; Gutierrez, J.A.; Rempel, S. A. PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration bysuppressing SHC-RAF-ERK and AKT signaling. Neuro-Oncology, 2010, Advance Access, noq048.
88. Okamoto, I.; Kawano, Y.; Tsuiki, H.; Sasaki, J.-I.; Nakao, M.; Matsumoto, M.; Suga, M.; Ando, M.; Nakajima, M.; Saya, H.CD44 cleavage induced by a membrane-associated metalloproteaseplays a critical role in tumor cell migration. Oncogene, 1999, 18(7), 1435-1446.
89. Kajita, M.; Itoh, Y.; Chiba, T.; Mori, H.; Okada, A.; Kinoh, H.; Seiki, M. Membrane-type 1 matrix metalloproteinasecleaves Cd44 and promotes cell migration. J. Cell Biol., 2001, 153(5), 893-904.
90. Yu, Q.; Stamenkovic, I. Localization of matrix metalloproteinase 9to the cell surface provides a mechanism for CD44-mediated tumorinvasion. Genes Dev., 1999, 13(1), 35-48.
91. Murai, T.; Miyazaki, Y.; Nishinakamura, H.; Sugahara, K. N.; Miyauchi, T.; Sako, Y.; Yanagida, T.; Miyasaka, M. Engagementof CD44 promotes rac activation and CD44 cleavage during tumorcell migration. J. Biol. Chem., 2004, 279 (6), 4541-4550.
92. Mendelsohn, C. L.; Wimmer, E.; Racaniello, V. R. Cellularreceptor for poliovirus: Molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulinsuperfamily. Cell, 1989, 56(5), 855-865.
93. Sloan, K.; Eustace, B.; Stewart, J.; Zehetmeier, C.; Torella, C.; Simeone, M.; Roy, J.; Unger, C.; Louis, D.; Ilag, L.; Jay, D.CD155/PVR plays a key role in cell motility during tumor cellinvasion and migration. BMC Cancer, 2004, 4(1), 73.
94. Sloan, K. E.; Stewart, J. K.; Treloar, A. F.; Matthews, R. T.; Jay, D.G. CD155/PVR enhances glioma cell dispersal by regulatingadhesion signaling and focal adhesion dynamics. Cancer Res., 2005, 65(23), 10930-7.
95. Sloan, K. E.; Stewart, J. K.; Treloar, A. F.; Matthews, R. T.; Jay, D.G. CD155/PVR enhances glioma cell dispersal by regulatingadhesion signaling and focal adhesion dynamics. Cancer Res., 2005, 65(23), 10930-10937.
96. Barbero, S.; Bonavia, R.; Bajetto, A.; Porcile, C.; Pirani, P.; Ravetti, J. L.; Zona, G. L.; Spaziante, R.; Florio, T.; Schettini, G.Stromal cell-derived factor 1α stimulates human glioblastoma cellgrowth through the activation of both extracellular signal-regulatedkinases 1/2 and Akt. Cancer Res., 2003, 63(8), 1969-1974.
97. Wu, M.; Chen, Q.; Li, D.; Li, X.; Li, X.; Huang, C.; Tang, Y.; Zhou, Y.; Wang, D.; Tang, K.; Cao, L.; Shen, S.; Li, G. LRRC4inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1alpha/CXCR4-mediatedERK1/2 and Akt signaling pathways. J. Cell. Biochem., 2008, 103(1), 245-255.
98. Zhang, J.; Sarkar, S.; Yong, V. W. The chemokine stromal cellderived factor-1 (CXCL12) promotes glioma invasiveness throughMT2-matrix metalloproteinase. Carcinogenesis, 2005, 26(12), 2069-2077.
99. Hoelzinger, D. B.; Nakada, M.; Demuth, T.; Rosensteel, T.; Reavie, L. B.; Berens, M. E. Autotaxin: a secretedautocrine/paracrine factor that promotes glioma invasion. J. Neurooncol., 2008, 86(3), 297-309.
100. Malchinkhuu, E.; Sato, K.; Horiuchi, Y.; Mogi, C.; Ohwada, S.; Ishiuchi, S.; Saito, N.; Kurose, H.; Tomura, H.; Okajima, F. Role of p38 mitogen-activated kinase and c-Jun terminal kinase inmigration response to lysophosphatidic acid and sphingosine-1-phosphate in glioma cells. Oncogene, 2005, 24(44), 6676-6688.
101. Shashidhar, S.; Lorente, G.; Nagavarapu, U.; Nelson, A.; Kuo, J.; Cummins, J.; Nikolich, K.; Urfer, R.; Foehr, E. D. GPR56 is aGPCR that is overexpressed in gliomas and functions in tumor celladhesion. Oncogene, 2005, 24(10), 1673-82.
102. Shashidhar, S.; Lorente, G.; Nagavarapu, U.; Nelson, A.; Kuo, J.; Cummins, J.; Nikolich, K.; Urfer, R.; Foehr, E. D. GPR56 is aGPCR that is overexpressed in gliomas and functions in tumor celladhesion. Oncogene, 2005, 24(10), 1673-1682.
103. Esteve, P.-O.; Tremblay, P.; Houde, M.; St-Pierre, Y.; Mandeville, R. In vitro expression of MMP-2 and MMP-9 inglioma cells following exposure to inflammatory mediators.Biochim. Biophys. Acta (BBA) - Mol. Cell Res., 1998, 1403(1), 85-96.
104. Esteve, P. O.; Chicoine, E.; Robledo, O.; Aoudjit, F.; Descoteaux, A.; Potworowski, E. F.; St-Pierre, Y. Protein kinase C-ζ regulates transcription of the matrix metalloproteinase-9 geneinduced by IL-1 and TNF-α in glioma cells via NF-κ B. J. Biolo.Chem., 2002, 277(38), 35150-35155.
105. Krammer, P. H. CD95's deadly mission in the immune system.Nature, 2000, 407 (6805), 789-795.
106. Suda, T.; Takahashi, T.; Golstein, P.; Nagata, S. Molecular cloningand expression of the fas ligand, a novel member of the tumornecrosis factor family. Cell 1993, 75 (6), 1169-1178.
107. Barnhart, B. C.; Legembre, P.; Pietras, E.; Bubici, C.; Franzoso, G.; Peter, M. E. CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J, 2004, 23(15), 3175-85.
108. Kumar, M.; Makonchuk, D. Y.; Li, H.; Mittal, A.; Kumar, A. TNFlikeweak inducer of apoptosis (TWEAK) activatesproinflammatory signaling pathways and gene expression throughthe activation of TGF-{beta}-activated kinase 1. J. Immunol., 2009, 182(4), 2439-2448.
109. Panner, A.; Crane, C. A.; Weng, C.; Feletti, A.; Fang, S.; Parsa, A.T.; Pieper, R. O. Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAILsensitivity in glioblastoma multiforme. Cancer Res., 2010, 70(12), 5046-53.
110. Bettinger, I.; Thanos, S.; Paulus, W. Microglia promote gliomamigration. Acta Neuropathol., 2002, 103(4), 351-355.
111. Wagner, S.; Czub, S.; Greif, M.; Vince, G. H.; Suss, N.; Kerkau, S.; Rieckmann, P.; Roggendorf, W.; Roosen, K.; Tonn, J. C.Microglial/macrophage expression of interleukin 10 in humanglioblastomas. Int. J. Cancer, 1999, 82(1), 12-6.
112. Webb, T. R.; Slavish, J.; George, R. E.; Look, A. T.; Xue, L.; Jiang, Q.; Cui, X.; Rentrop, W. B.; Morris, S. W. Anaplasticlymphoma kinase: role in cancer pathogenesis and small-moleculeinhibitor development for therapy. Expert Rev. Anticancer Ther., 2009, 9(3), 331-56.
113. Lu, K. V.; Jong, K. A.; Kim, G. Y.; Singh, J.; Dia, E. Q.; Yoshimoto, K.; Wang, M. Y.; Cloughesy, T. F.; Nelson, S. F.; Mischel, P. S. Differential induction of glioblastoma migration and growth by two forms of pleiotrophin. J. Biol. Chem., 2005, 280(29), 26953-26964.
114. Baker, B. J.; Park, K. W.; Qin, H.; Ma, X.; Benveniste, E. N.IL-27 inhibits OSM-mediated TNF-alpha and iNOS geneexpression in microglia. Glia, 2010, 58(9), 1082-1093.
115. Krona, A.; Aman, P.; Orndal, C.; Josefsson, A. Oncostatin M-inducedgenes in human astrocytomas. Int. J. Oncol., 2007, 31(6), 1457-63.
116. Kanu, O.; B Hughes; Di, C.; Lin, N.; Fu, J.; Bigner, D.; Yan, H.; Adamson, D. Glioblastoma multiforme oncogenomics and signaling pathways. Clin. Med. Oncol., 2009, 3, 39-52.
117. Singh, S. K.; Clarke, I. D.; Terasaki, M.; Bonn, V. E.; Hawkins, C.; Squire, J.; Dirks, P. B. Identification of a cancer stem cell in humanbrain tumors. Cancer Res., 2003, 63(18), 5821-8.
118. Wakimoto, H.; Kesari, S.; Farrell, C. J.; Curry, W. T.; Zaupa, C.; Aghi, M.; Kuroda, T.; Stemmer-Rachamimov, A.; Shah, K.; Liu, T.-C.; Jeyaretna, D. S.; Debasitis, J.; Pruszak, J.; Martuza, R. L.; Rabkin, S. D. Human glioblastoma, äìderived cancer stem cells: establishment of invasive glioma models and treatment withoncolytic herpes simplex virus vectors. Cancer Res., 2009, 69(8), 3472-3481.
119. Lathia, J. D.; Gallagher, J.; Heddleston, J. M.; Wang, J.; Eyler, C.E.; MacSwords, J.; Wu, Q.; Vasanji, A.; McLendon, R. E.; Hjelmeland, A. B.; Rich, J. N. Integrin alpha 6 regulatesglioblastoma stem cells. Cell Stem Cell., 2010, 6(5), 421-432.
120. Mendez, O.; Zavadil, J.; Esencay, M.; Lukyanov, Y.; Santovasi, D.; Wang, S.-C.; Newcomb, E. W.; Zagzag, D. Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion invivo and impairs their ability to form tumor spheres. Mol. Cancer, 2010, 9, 133.
121. Hsieh, D.; Hsieh, A.; Stea, B.; Ellsworth, R. IGFBP2 promotesglioma tumor stem cell expansion and survival. Biochem. Biophys.Res. Commun., 2010, 397(2), 367-72.
122. Hjelmeland, A. B.; Wu, Q.; Wickman, S.; Eyler, C.; Heddleston, J.; Shi, Q.; Lathia, J. D.; MacSwords, J.; Lee, J.; McLendon, R. E.; Rich, J. N. Targeting A20 decreases glioma stem cell survival and tumor growth. PLoS Biol., 2010, 8(2), e1000319.
123. White, P. S.; Thompson, P. M.; Gotoh, T.; Okawa, E. R.; Igarashi, J.; Kok, M.; Winter, C.; Gregory, S. G.; Hogarty, M. D.; Maris, J.M.; Brodeur, G. M. Definition and characterization of a region of1p36.3 consistently deleted in neuroblastoma. Oncogene, 2005, 24(16), 2684-94.
124. Dong, Z.; Pang, J. S.; Ng, M. H.; Poon, W. S.; Zhou, L.; Ng, H. K.Identification of two contiguous minimally deleted regions onchromosome 1p36.31-p36.32 in oligodendroglial tumours. Br. J.Cancer, 2004, 91(6), 1105-11.
125. Bharti, S.; Handrow-Metzmacher, H.; Zickenheiner, S.; Zeitvogel, A.; Baumann, R.; Starzinski-Powitz, A. Novel membrane proteinshrew-1 targets to cadherin-mediated junctions in polarizedepithelial cells. Mol. Biol. Cell, 2004, 15(1), 397-406.
126. Schreiner, A.; Ruonala, M.; Jakob, V.; Suthaus, J.; Boles, E.; Wouters, F.; Starzinski-Powitz, A. Junction protein shrew-1influences cell invasion and interacts with invasion-promotingprotein CD147. Mol. Biol. Cell., 2007, 18(4), 1272-1281.
127. Schwechheimer, K.; Zhou, L.; Birchmeier, W. E-Cadherin inhuman brain tumours: loss of immunoreactivity in malignantmeningiomas. Virch. Arch., 1998, 432 (2), 163-7.
128. Utsuki, S.; Sato, Y.; Oka, H.; Tsuchiya, B.; Suzuki, S.; Fujii, K. Relationshipbetween the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas. J. Neurooncol., 2002, 57(3), 187-92.
129. Utsuki, S.; Oka, H.; Sato, Y.; Kawano, N.; Tsuchiya, B.; Kobayashi, I.; Fujii, K. Invasive meningioma is associated with alow expression of E-cadherin and beta-catenin. Clin. Neuropathol., 2005, 24(1), 8-12.
130. McDonald, J. M.; Dunlap, S.; Cogdell, D.; Dunmire, V.; Wei, Q.; Starzinski-Powitz, A.; Sawaya, R.; Bruner, J.; Fuller, G. N.; Aldape, K.; Zhang, W. The SHREW1 gene, frequently deleted inoligodendrogliomas, functions to inhibit cell adhesion and migration. Cancer Biol. Ther., 2006, 5(3), 300-4.
131. Grzmil, M.; Hemmings, B. A. Deregulated signalling networks inhuman brain tumours. Biochim. Biophys. Acta (BBA) - Prot.Proteom., 2010, 1804(3), 476-483.
132. Rusciano, D.; Lorenzoni, P.; Burger, M. M. Constitutiveactivation of c-Met in liver metastatic B16 melanoma cells dependson both substrate adhesion and cell density and is regulated by acytosolic tyrosine phosphatase activity. J. Biol. Chem., 1996, 271(34), 20763-20769.
133. Sundberg, C.; Rubin, K. Stimulation of beta1 integrins on fibroblasts induces PDGF independent tyrosinephosphorylation of PDGF beta-receptors. J. Cell Biol., 1996, 132(4), 741-752.
134. Moro, L.; Venturino, M.; Bozzo, C.; Silengo, L.; Altruda, F.; Beguinot, L.; Tarone, G.; Defilippi, P. Integrins induceactivation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. EMBO J., 1998, 17(22), 6622-6632.
135. Wang, R.; Kobayashi, R.; Bishop, J. M. Cellularadherence elicits ligand-independent activation of the Met cellsurfacereceptor. Proc. Natl. Acad. Sci. USA, 1996, 93(16), 8425-8430.
136. Van Brocklyn, J. R. Sphingolipid signaling pathways as potentialtherapeutic targets in gliomas. Mini Rev. Med. Chem., 2007, 7, 984-990.